News Image

What's going on in today's session

By Mill Chart

Last update: Apr 26, 2024

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.

Today's top gainers

TickerChangeComment
ATXI6.0K%AVENUE THERAPEUTICS INC (NASDAQ:ATXI) experienced a significant 6.0K% increase, reaching $7.66 during Friday's session. In the last month the share price dropped with 23.33%.
ZVSA682.0%ZYVERSA THERAPEUTICS INC (NASDAQ:ZVSA) rose 682.0% to $4.77 during Friday's after hours session. In the last month the share price dropped with 21.87%.
BDRX59.72%BIODEXA PHARMACEUTICALS-ADR (NASDAQ:BDRX) experienced a significant 59.72% increase, reaching $1.15 during Friday's session. The stock is trading 62.05% lower than 3 months ago.
PEGY46.44%PINEAPPLE ENERGY INC (NASDAQ:PEGY) witnessed a notable 46.44% uptick in its shares, reaching $0.08 during Friday's session. The stock is trading 89.82% lower than 3 months ago.
FCUV37.61%FOCUS UNIVERSAL INC's (NASDAQ:FCUV) shares rose 37.61% to $0.39. Shareholders saw the stock price going 36.38% lower in the past month.
SAVAW35.44%CASSAVA SCIENCES INC-28's (NASDAQ:SAVAW) stock price displayed strong growth, advancing 35.44% and reaching $0.42 during Friday's session. The stock is trading 92.44% lower than a month ago.
SBFM35.01%Positive market sentiment drove SUNSHINE BIOPHARMA INC's (NASDAQ:SBFM) stock price up by 35.01% to $1.09 during Friday's session. The stock is trading 85.84% lower than a month ago.
BOF34.18%Investors witnessed a remarkable 34.18% rise in BRANCHOUT FOOD INC/OR's (NASDAQ:BOF) shares, which climbed to $2.63 during Friday's session. The stock is trading 70.43% higher than 3 months ago.
AGEN33.19%AGENUS INC's (NASDAQ:AGEN) shares soared 33.19% to $11.05 during Friday's session. In the last month the share price dropped with 25.41%.
CGEM31.64%In an impressive move, CULLINAN THERAPEUTICS INC's (NASDAQ:CGEM) shares recorded a 31.64% increase, closing at $25.34 during Friday's session. Shareholders saw the stock price going 47.28% higher in the past 3 months.

Our top gainers page will show you the full list.

Losers

TickerChangeComment
NUWE-42.04%NUWELLIS INC's (NASDAQ:NUWE) shares fell 42.04% to $0.17. In the last month the share price dropped with 26.61%.
EJH-29.61%Investors witnessed a 29.61% drop in E-HOME HOUSEHOLD SERVICE's (NASDAQ:EJH) stock price, which closed at $0.54 during Friday's session. Shareholders saw the stock price going 41.67% lower in the past month.
SGBX-27.4%SAFE & GREEN HOLDINGS CORP's (NASDAQ:SGBX) stock price is declining with 27.4% to a price of $0.16. A press release (Safe & Green Holdings Announces it Has Entered Into an Agreement to Produce Four Modular Electrical Distribution Centers as Part of a Multi-Unit Order for a Client Serving the Big Box Retailer Market) was released yesterday.
BACK-23.92%During Friday's session, IMAC HOLDINGS INC's (NASDAQ:BACK) shares took a tumble, falling 23.92% to $3.88. In the last month the stock gained 67.21%.
SAIA-21.51%SAIA INC's (NASDAQ:SAIA) stock price is declining with 21.51% to a price of $426.19. SAIA INC released earnings Yesterday. Earlier today the company had a press release: Saia Announces Upcoming Retirement of CFO Douglas Col.
AIRE-17.27%Investors witnessed a 17.27% decrease in REALPHA TECH CORP's (NASDAQ:AIRE) stock price, which closed at $1.15 during Friday's session. The stock is trading 94.0% lower than 6 months ago.
ACON-17.01%ACLARION INC (NASDAQ:ACON) encountered a 17.01% decrease in its shares, reaching $0.33 during Friday's session. In the last month the share price increased with 20.65%.
XFOR-16.88%X4 PHARMACEUTICALS INC (NASDAQ:XFOR) encountered a 16.88% decrease in its shares, reaching $0.94 during Friday's session. The stock is trading 45.84% higher than 3 months ago.
VWE-16.79%Investors witnessed a 16.79% decrease in VINTAGE WINE ESTATES INC's (NASDAQ:VWE) stock price, which closed at $0.2 during Friday's session. In the last month the share price dropped with 33.61%.
KNSL-16.22%There was a notable decline in KINSALE CAPITAL GROUP INC's (NYSE:KNSL) shares, as they dropped 16.22% to $379.58 during Friday's session. In the last 6 months the stock gained 32.15%.

For the full top loser list go to our top losers page.

Back

X4 PHARMACEUTICALS INC

NASDAQ:XFOR (5/17/2024, 7:00:03 PM)

After market: 0.9436 +0.02 (+1.64%)

0.9284

-0.03 (-3.26%)

XFOR News

News Image5 days ago - X4 PharmaceuticalsX4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the...

News Image9 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!

News Image9 days ago - X4 PharmaceuticalsX4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility

$125 million of non-dilutive capital extends projected cash runway into late 2025, excluding expected commercial sales from XOLREMDI™ (mavorixafor) ...

News Image11 days ago - InvestorPlaceXFOR Stock Earnings: X4 Pharmaceuticals Misses EPS for Q1 2024

XFOR stock results show that X4 Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.

News Image11 days ago - X4 PharmaceuticalsX4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates

U.S. launch underway for XOLREMDI™ (mavorixafor) in WHIM syndrome XOLREMDI Phase 3 4WHIM clinical trial data published online in Blood, the...

News Image17 days ago - X4 PharmaceuticalsX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the...

News Image19 days ago - X4 PharmaceuticalsX4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome

XOLREMDI targets CXCR4 pathway dysfunction, the underlying cause of WHIM syndrome Breakthrough Therapy approval follows Priority Review of 4WHIM Phase 3...

News Image2 months ago - X4 PharmaceuticalsX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the...

News Image2 months ago - Market News VideoCommit To Buy X4 Pharmaceuticals At $1, Earn 48.2% Annualized Using Options
News Image2 months ago - X4 PharmaceuticalsX4 Pharmaceuticals to Participate in Upcoming April Investor Conferences

BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the...

News Image2 months ago - InvestorPlaceXFOR Stock Earnings: X4 Pharmaceuticals Beats EPS for Q4 2023

XFOR stock results show that X4 Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.

News Image2 months ago - BusinessInsiderXFOR Stock Earnings: X4 Pharmaceuticals Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips X4 Pharmaceuticals (NASDAQ:XFOR) just reported results for the fourth quarter o...

XFOR Links
Follow us for more